Filing Details

Accession Number:
0000899243-22-000188
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-01-03 19:57:06
Reporting Period:
2021-12-29
Accepted Time:
2022-01-03 19:57:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1743881 Bridgebio Pharma Inc. BBIO () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1679076 Andrew Lo C/O Bridgebio Pharma, Inc.
421 Kipling Street
Palo Alto CA 94301
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-12-29 6,000 $12.90 46,599 No 4 P Direct
Common Stock Acquisiton 2021-12-30 1,500 $14.30 48,099 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 205,583 Indirect By Andrew W. Lo and Nancy N. Lo JTWROS